Is Your Company 'Corpomorphic'?
By Fintan Walton
Pharma Deals Review: Vol 2006 Issue 67 (Table of Contents)
Published: 1 Jan-2006
DOI: 10.3833/pdr.v2006.i67.579 ISSN: 1756-7874
Section: Business Commentaries
Fulltext:
Abstract
Which business model should a biotech company adopt? Changing attitudes and fluctuating financial markets make it very difficult for companies to set a long-term vision to a particular business model. However, the ability to morph from one business model to another is characteristic of many companies.
Copyright: © IQVIA 2018
Last Issue PDF
RSS